Agenus Inc. (NASDAQ:AGEN) is one of the most undervalued penny stocks to buy right now. On February 19, Agenus presented new translational and clinical biomarker data from its Phase 1b C-800-01 trial, ...

Battlefield 6 Season 2 has finally arrived, and after some time with its early offerings—now and at an earlier playtest—it's a clear improvement on its predecessor. It’s a subtly strong step forward, ...

Watching a Rom-Com this Valentine's Day? Before you get swept away, let's talk about the science of love vs. the magic of Hollywood. Watching a Rom-Com this Valentine's Day? Before you get swept away, ...

From small publishers to US federal agencies, websites are reporting unusual spikes in automated traffic linked to IP addresses in Lanzhou, China. When he first noticed the traffic spike, Quintero ...

Seedance 2.0, the new AI video model from TikTok‘s Chinese owner ByteDance, is going viral for apparently regurgitating Hollywood intellectual property on an epic scale. Launched this week, Seedance 2 ...

A phase 2 asthma study of Upstream Bio’s TSLP receptor antagonist has hit its primary endpoint. But, with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...